Pediatric nephrology (Berlin, Germany)
Belimumab combined with mycophenolate mofetil in a child with frequently relapsing, steroid-dependent nephrotic syndrome.
Yi Mao, Jia He, Weijie Kang, Jialu Lu, Lei Yin, Youying Mao
Published: 202510.1007/s00467-025-07084-7
Abstract
Frequently relapsing, steroid-dependent nephrotic syndrome (FRNS/SDNS) remains a therapeutic challenge. Rituximab, a B-cell-depleting agent, is effective and widely used for FRNS/SDNS, but its use can be limited by rare, serious adverse effects. Beli…
Preview only. Read the full abstract at the source